University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 8 of 23
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
NCT04051320
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial
NCT04173572
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
NCT04129931
SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF
NCT04415489
Setria Performance Blend Supplementation
NCT04090138
Targeted Lifestyle Change Group Prenatal Care
NCT04090307
Therapist Education and Massage for Parent Infant-Outcomes
NCT04121897
Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers
NCT04058886
HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program
NCT04131816
Improving Physical Activity and Gait Symmetry After Total Knee Arthroplasty
NCT04090125
Wrist Fracture Evaluation With a Desktop Orthopedic Tomosynthesis System
NCT03993691
Therapeutic Writing to Reduce Stress
NCT03904979
Comparing and Interactive Concussion Education Platform to Current Education Standards
NCT04122274
Adaptation of a Digital Weight Loss Intervention Promoting Self-regulation for Use in Type 2 Diabetes
NCT03650088
Atlas of Experimental Gingivitis in Humans
NCT04105569
Study to Assess Gonorrhoeae Immune Responses Induced by a N. Meningitidis Vaccine
NCT04094883
Designing Impactful Warnings for Sugary Drinks
NCT04382599
Integrating PrEP Into Family Planning Services at Title X Clinics in the Southeastern US
NCT04097834
Oral Hygiene in Assisted Living
NCT03892200
Improving Access to Early Psychosis Coordinated Specialty Care
NCT04277585
Effect of Palmitoleic Acid on C-reactive Protein
NCT03625427
Glucose and Non-Invasive Brain Stimulation
NCT04031404
Video-based Collaborative Learning to Improve Ventral Hernia Repair
NCT04173884
Caffeine for Hypoxic-Ischemic Encephalopathy
NCT03913221
Mobile Methods for Reducing Obesity Risk in Parents and Children
NCT03973424
Woodsmoke Particulate + Hypertonic Saline
NCT03851406
Development of a Novel Transdiagnostic Intervention for Anhedonia - R33 Phase
NCT04036136
Peak Inspiratory Flow Rates in Patients With COPD
NCT04168775
Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation
NCT04032613
Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)
NCT04852666
Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis
NCT03906227
Optimizing Overactive Bladder Treatment
NCT03904407
Momentum-enabled Treadling Methodology to Improve Gait and Enhance Mobility
NCT03891641
Internet-Based Pain Coping Skills Training for Patients With Lupus
NCT03933839
P3 (Prepared, Protected, emPowered)
NCT03320512
Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM)
NCT03414372
Community-associated Highly-Resistant Enterobacterales
NCT03924934
Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults
NCT03844386
Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation
NCT03780387
Evaluation of an Enhanced Delivery Model for Go NAPSACC
NCT03938103
A Strategy to Reduce Opioid Drug Prescribing by Clinicians
NCT03809507
The Use of an Online Learning and Consent Platform in Infertility Treatment
NCT03962257
Certified Nursing Assistants' Wellbeing
NCT03720652
Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI Tract
NCT03917420
Woodsmoke Particulate + Prednisone
NCT03861390
Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP)
NCT03780400
Mepo for Eosinophilic Esophagitis (EoE) Study
NCT03656380
MR Fingerprinting: A Novel Sequence Applied to Neuroimaging
NCT03800537
Connect-Home Clinical Trial
NCT03810534
Essential Amino Acids and High Intensity Interval Training
NCT04080102
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.